Key point: The President’s latest Executive Order establishes the Genesis Mission and aspires to use AI to accelerate scientific discovery in sectors such as biotech, quantum, nuclear power, and semiconductors.
Key point: Recent legislative efforts in Massachusetts, seeking to add another comprehensive data privacy law to the national patchwork of state laws, and in California enacting a law to regulate AI development, occurred this week when the Massachusetts Senate unanimously sent Senate Bill 2608 to the state House, and California enacted the nation’s second substantive state law regulating AI.
Key point: The California Legislature is considering a bill that would impose comprehensive requirements on the development, deployment, and use of artificial intelligence (AI) systems, with a focus on transparency, accountability, and risk mitigation.
Keypoint: Virginia becomes the second legislature – after Colorado – to pass an algorithmic discrimination bill – although the bill still needs to get through the state’s Republican governor to become law.
On February 20, Virginia’s Democrat-controlled legislature passed the Virginia High-Risk Artificial Intelligence Developer and Deployer Act (HB 2094). The bill next
Welcome to the second edition of Byte Back AI, a weekly newsletter providing updates on proposed state AI bills and regulations, an AI bill tracker chart, summaries of important AI hearings, and special features. Starting January 6, 2025, Byte Back AI will be available only to paid subscribers. For more information on subscriptions, please click here.
As always, the contents provided below are time-sensitive and subject to change.
Welcome to the first edition of Byte Back AI, a weekly newsletter providing updates on proposed state AI bills and regulations, an AI bill tracker chart, summaries of important AI hearings, and special features. The first two editions of Byte Back AI will be released for free on Byte Back. Starting January 6, 2025, Byte Back AI will be available only to paid subscribers. For more information on subscriptions, please click here.
Read the second complimentary edition here.
As always, the contents provided below are time-sensitive and subject to change.
Keypoint: The New York Department of Financial Services (NYDFS) circulated an industry letter offering guidance to NYDFS “Covered Entities” for assessing and managing AI-related cybersecurity risks, including threats malicious actors using AI and the risks associated with a Covered Entity’s own AI systems.
The NYDFS industry letter (“Letter”) recognizes that Covered Entities can leverage AI to enhance their cybersecurity posture. The department contends that doing so would bolster entities’ compliance with NYDFS cybersecurity regulation 23 NYCRR Part 500 (“Part 500”).
Keypoint: Of the ten privacy- and AI-related bills passed by the California legislature in the 2024 legislative session, Governor Newsom signed seven into law and vetoed three by the September 30 deadline.
Throughout the 2024 legislative session, we have been tracking numerous privacy- and AI-related bills pending in California. Ten of those bills passed the state legislature before the legislative session ended on August 31 (nine of which passed in the final week of August). Governor Newsom had a deadline of September 30 to sign or veto the bills that passed. Of the ten total bills, he signed seven into law and vetoed three bills. Those seven bills scheduled to go into effect consist of four laws related to privacy and three laws related to AI.
The below article provides a summary of the ten bills that Governor Newsom either signed into law or vetoed.
Keypoint: The Texas Attorney General reaches a first-of-its-kind settlement with a healthcare company that provides generative AI products.
On September 18, 2024, the Texas Attorney General announced that it had reached a settlement with a Dallas-based artificial intelligence healthcare company. The Attorney General’s press release represents that it is a first-of-its-kind settlement, resolving allegations that the company deployed its artificial intelligence (“AI”) products at Texas hospitals while making false and misleading statements about the safety of its products.